Skip to main content

Maury Raycroft

Analyst

Jeffries

Equibles does not estimate personal net worth.

About Maury Raycroft

Maury Raycroft is recorded as Analyst at Jeffries. Maury Raycroft has spoken on 2 earnings calls and 1 other investor event across 3 companies, most recently for Sangamo Therapeutics, Inc on March 30, 2026. Those appearances were for Sangamo Therapeutics, Inc (SGMOQ), Beam Therapeutics Inc. (BEAM) and KalVista Pharmaceuticals, Inc.. The companies whose calls Maury Raycroft spoke on are classified in the Healthcare sector.

Maury Raycroft on recent calls

“Just to start off, can you provide more color on the revised timing for the FABRI BLA submission? What PPQ and other CMC-related activities are the primary gating factors here?”
Analyst — Jeffries, Sangamo Therapeutics, Inc Q4 FY2025 Earnings Call ·
“For the in vitro data that you have for the different variants, can you just provide more specifics on how much of that you already have?”
Analyst — Jeffries, Beam Therapeutics Inc. Q4 FY2025 Earnings Call ·
“Just based on the patient interest you're seeing from your awareness website and doctor interest, how are you setting expectations for the early launch?”
Analyst — Jeffries, Ekterly FDA Approval Conference Call ·

Affiliation history

  • Jeffries

    Analyst

    Transcript header (unverified)

    Current

Company network

KalVista Pharmaceuticals, Inc.

Biotechnology · Healthcare

1 appearance Latest appearance 2025-07-07

Recent activity